# Correction to: Role of antibody engineering in generation of derivatives starting from MOv19 MAb: 40 years of biological/therapeutic tools against folate receptor alfa

PMC · DOI: 10.1093/abt/tbae010 · 2024-05-15

## Full-text entities

- **Cell lines:** MOv19 — Mus musculus (Mouse), Hybridoma (CVCL_LH61)

---
Source: https://tomesphere.com/paper/PMC11200684